Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
Abstract Background Atrial fibrillation is the most common arrhythmia of the heart with a prevalence of approximately 2% in the western world. Atrial flutter, another arrhythmia, occurs less often with an incidence of approximately 200,000 new patients per year in the USA. Patients with atrial fibri...
Main Authors: | Naqash J. Sethi, Sanam Safi, Joshua Feinberg, Emil E. Nielsen, Christian Gluud, Janus C. Jakobsen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | Systematic Reviews |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13643-017-0470-2 |
Similar Items
-
What Is the Optimal Digoxin Level? Challenging Case of Fetal Atrial Flutter Treatment in a Monochorionic Diamniotic Twin
by: Soo Jung Kim, et al.
Published: (2023-06-01) -
Fatores preditores de fibrilação atrial após ablação do flutter atrial típico Factores predictores de fibrilación atrial tras ablación del flutter atrial típico Predictors of atrial fibrillation after ablation of typical atrial flutter
by: Sissy Lara de Melo, et al.
Published: (2009-11-01) -
A Comparison of Verapamil and Digoxin for Heart Rate Control in Atrial Fibrillation
by: Mohammad Afzali Moghadam, et al.
Published: (2012-08-01) -
Cardioversion in Infantile Atrial Flutter
by: Andaleeb Ara, et al.
Published: (2022-11-01) -
Interpretation of uncommon ECG findings in patients with atrial flutter
by: Mykhaylo S. Sorokivskyy, et al.
Published: (2017-04-01)